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ABSTRACT
Skin conditions such as psoriasis, eczema, and
skin cancer often have a substantial psychologic
and social impact on our patients. Some of
these patients limit their life because they
feel self-conscious about their symptoms.
Sometimes, greater life satisfaction comes from
accepting that perhaps some symptoms will
remain or recur, even in an individual who
responds well to treatment. This acceptance
involves acknowledging the existence of
symptoms, thereby allowing the patient to
pursue a meaningful life that is not overly
limited by their potential presence. This is not
only liberating for the patient but also for the
medical professional, who can sometimes feel
pressured by patients’ unrealistic expectations to
achieve symptom reductions that are not
possible. We discuss how to talk with patients
about their expectations regarding treatment
and whether relief of symptoms is a necessary
component to living a better life. Helping
patients to find the right words to explain their
visible symptoms to others can sometimes help
them feel less self-conscious in public settings
and thereby more comfortable going out into the
world to pursue a meaningful life.
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INTRODUCTION
Patients with conditions such as psoriasis,
eczema, and skin cancer frequently face
psychologic challenges which, in turn, impact
their social functioning and the kind of life that
they lead [1]. Patients may experience fearful
anticipation of interaction with others, even
when symptoms are not present, and develop
avoidance-coping mechanisms. This may
prevent them from partaking fully, or at all, in
social and recreational activities or employment.
Ultimately, visible symptoms may change how
patients see themselves and how they perceive
their future.
Multiple studies reveal consistently poorer
quality of life and psychosocial functioning
scores among patients with visible
dermatologic skin conditions compared with
those who do not have such conditions [2–5].
The incidence of psychosocial comorbidities
among such patients is high, as evidenced by a
study which found that the risks of depression,
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anxiety, and suicidality attributable to psoriasis
were 11.8, 8.1, and 0.4 per 1000 person–years,
respectively (Table 1) [5].
The dermatologist can play an important role
in helping patients to overcome such substantial
challenges and improve their overall quality of
life. We discuss several important considerations
and propose strategies to assist dermatologists
in addressing the important psychosocial side





Studies have shown that successful treatment,
which improves the patient’s symptoms and
changes their physical appearance, can lead to
improvement in psychologic symptoms and a
better quality of life [2, 6]. However, it is
important to note that, sometimes, greater life
satisfaction is achieved by accepting that
perhaps some symptoms will remain or recur,
even if a patient generally responds well
to treatment. Such acceptance involves
acknowledging the existence of symptoms, but
frees up the patient to pursue a meaningful life
that is not overly limited by their condition.
Thus, treating a patient’s physical symptoms
is only half the battle. It is also crucial that
patients are provided with the tools to accept
their remaining symptoms and to reduce the
impact of these on everyday life.
MANAGEMENT OF PATIENT
EXPECTATIONS
As a clinician, one is familiar with the broad
spectrum of available treatment options and the
tools used to objectively measure outcomes in a
clinical and/or academic setting. Treatment
may be deemed successful if improvements in
physical symptoms are in line with the results
one would typically observe in other patients,
or those that have been reported in clinical
trials. However, it is important to remember
that other factors may influence the patient’s
own perception of treatment success.
Patients have their own preferences and
priorities regarding what treatment outcomes
are more important to them. For example, one
patient may favor reduction or elimination of
signs of disease that are visible to others when
wearing typical clothes (which may change
with the season), whereas another patient may
be more interested in reducing their level
of physical discomfort. Patients’ satisfaction
is strongly influenced by their initial
expectations and the changes they were
expecting to see, as well as those of their
family and friends; objective measures of
symptom improvement may be less important
to them.
Therefore, when evaluating treatment
options, it is important to consider asking the
patient what outcomes are most important to
them and to discuss what it is reasonably
possible to achieve. This will contribute to
making treatment more successful, as defined
by the patients. As such, a broad outcome
measure that includes psychosocial and overall
quality of life measures, in addition to symptom
remission, would be of particular value.
Table 1 The attributable risk of psoriasis for diagnosis
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Clinicians have the opportunity to actively
manage patients’ expectations. In order to
achieve this, clinicians may wish to discuss
expected outcomes before treatment is
initiated, including the degree of symptom
improvement that can realistically be
expected, the likelihood of success, and the
timescales involved. This would ideally be a
two-way conversation, in which the clinician
could ask the patient to explain their hopes and
expectations as a result of their treatment.
There are several ways in which realistic
expectations (i.e. not too high and not too low)
will result in the best outcome for the patient.
Firstly, the likelihood of good treatment
compliance is increased. If expectations are
sufficiently high, a patient is more likely to be
willing to initiate treatment and remain
compliant, as they will be confident that they
will eventually see an improvement in their
symptoms. Similarly, if they have a tempered
understanding of the expected degree of
improvement, and when this may occur, they
will be more likely to adhere to treatment
without getting discouraged by seemingly poor
results. This is especially important in the case
of complicated regimens, such as those
associated with frequent or inconvenient drug
administration, those that involve some degree
of pain or discomfort, or those in which
extensive treatment is required before
symptoms begin to improve.
Secondly, appropriate expectations can help
a patient and their family to know when they
need to return to the clinician and ask for a
different treatment approach. Such a dynamic,
interactive relationship between the clinician
and the patient can ensure that the patient’s
needs are being met wherever possible, and may
reduce unnecessary time and costs associated
with treatment that is inappropriate or
ineffective for that person.
Finally, focusing on the broad improvement
of patient quality of life, and not just on the
management of visible symptoms, may help to
reduce the often excessive pressure placed on
healthcare providers by patients with unrealistic
expectations for improvement. This can
improve the clinician’s own sense of job
satisfaction, as well as the overall relationship
between the clinician and the patient.
LIFE BEYOND SYMPTOMS:
HELPING PATIENTS TO PREVENT
SYMPTOMS FROM BECOMING
IMPAIRMENT
When considering treatment goals, it is
important to distinguish between symptoms
and impairment. Symptoms can be defined as
the distinguishing clinical features of a disorder.
Impairment, however, is defined as the
suffering that can be caused by symptoms, and
may be physical, psychologic, and/or social.
The degree of impairment caused by a given
symptom is often different in different people;
in fact, a patient can have a severe symptom but
not be impaired by it at all. Conversely, a
different patient may be greatly impaired by
symptoms of relatively mild severity, with a
tremendously negative impact on their life. For
example, an insecure teenager may feel
extremely self-conscious about minor acne and
avoid some social situations, whereas a
confident young adult with much worse
symptoms may hardly think about them.
When it comes to reducing the psychologic
impact of a dermatologic condition and
improving the patient’s quality of life, it is
crucial that we address impairment and not just
symptoms. It is possible for a patient to actively
refuse to be unnecessarily limited by their
symptoms, rather than be passively resigned to
them. However, support and encouragement are
often needed in order for a patient to achieve
this. As clinicians, we have the opportunity to
encourage patients to live ‘a big life’, i.e. a life
that is fulfilling, rewarding, meaningful, and
interesting, and that has a positive impact on the
world, in which the person accomplishes most of
what they set out to do. In turn, the patient may
strive to be the person that they want to be,
regardless of their health status. Other
professionals, such as nurses, psychotherapists,
or counsellors, who may be involved in the wider
healthcare circle of a patient, can also assist in
this regard. In some cases, an overly negative
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response to symptoms can be indicative of low
self-esteem, anxiety, or depression, which can
warrant a referral to a mental health professional
to help the patient cope, not only with
their dermatologic condition, but also with
other matters.
We can help patients to redefine themselves
by asking the question, ‘‘What would/could you
do if you did not have these symptoms?’’ It
should be emphasized that, although symptoms
may affect how a patient lives their life,
symptoms do not necessarily need to rule a
patient’s life. We can also help patients to
understand that tolerating discomfort may
allow them to pursue more interesting goals in
life. Mental health professionals can help more
limited patients to learn better coping methods
to deal with sometimes debilitating discomfort.
Patients should, of course, be encouraged to
follow the treatment regimen, and active
engagement with the clinician will enable the
patient to feel that they are in control of their
condition and their treatment program.
However, we can emphasize to patients that it
is important not to wait for complete symptom
remission before pursuing a fulfilled life.
HELPING PATIENTS TO DEVELOP
THE TOOLS TO EXPLAIN THEIR
SYMPTOMS
Some patients restrict their social engagement
because they feel self-conscious about their
visible symptoms and do not know how to
respond to people’s questions about them, such
as why they look that way, or whether the
condition is contagious. Helping patients find
the right words to explain their visible
symptoms to others can help them feel more
comfortable going out into the world. This is
particularly true of situations in which the
patient is likely to encounter people who are
more likely to make inappropriate comments,
ask personal questions, or make incorrect
assumptions, such as that the condition is
highly infectious. It is easier for the patient to
cope and feel confident in such situations if
they have an appropriate and informed range of
responses prepared in advance. Patients can
choose to share personal information, but they
also have the right not to do so.
CONCLUSIONS
Visible medical conditions such as psoriasis,
eczema, and skin cancer often have a
substantial psychologic and social impact on
patients. However, through appropriate
discussion and interaction with a patient, the
dermatologist can play an important role in
helping to reduce this impact, potentially
improving the patient’s overall quality of life.
It is important to discuss expected outcomes
before treatment is initiated, in order to ensure
that realistic expectations are in place. It may
also be beneficial to discuss whether total
symptom relief is a necessary component to
living a better life. In addition, helping patients
to find the right words to explain their visible
symptoms to others can help them feel less
self-conscious and more confident in a public
setting. Helping patients to come to terms with
their condition, and helping them to build the
skills required to reduce the psychosocial
impact of their condition, may mean that they
are more equipped to go out into the world and
pursue a more meaningful life.
This article is based on previously conducted
studies and does not involve any new studies of
human or animal subjects performed by any of
the authors.
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